Literature DB >> 8839355

Regulation of estrogen receptor concentrations in the rat brain: effects of sustained androgen and estrogen exposure.

T J Brown1, B Scherz, R B Hochberg, N J MacLusky.   

Abstract

To determine whether estrogen and androgens either alone or in combination downregulate estrogen receptors in the brain, ovariectomized/adrenalectomized female rats received one of the following four treatments: (1) one subcutaneously placed Silastic capsule containing 10% estradiol in cholesterol, (2) one capsule containing 10% estradiol and two capsules containing 100% 5 alpha-dihydrotestosterone (DHT), (3) two capsules containing DHT, or (4) empty Silastic capsules (control animals). Animals were killed 4 or 8 days after capsule insertion and the occupied, unoccupied and total estrogen receptor content in specific brain nuclei was determined by quantitative in vitro autoradiography. To determine if the effects of the androgen were reversible, DHT capsules were removed after 4 days from half of the estradiol+DHT-treated rats, and the animals were killed 4 days later. Estradiol downregulated estrogen receptor expression in the periventricular preoptic area, medial preoptic area, bed nucleus of the stria terminalis (BNST), arcuate nucleus (ARC), ventromedial nucleus (VMN), and medial and cortical amygdala, decreasing receptor content by 30-41% in animals treated for 4 days, and by 44-60% in animals treated for 8 days with estradiol alone. DHT treatment in combination with estradiol further decreased estrogen receptor content in the BNST, ARC and VMN, relative to the estradiol-only animals. DHT in the absence of estrogen was without effect. In animals in which the DHT capsules were removed after 4 days of exposure, allowing the estradiol to remain for a further 4 days, estrogen receptor levels were indistinguishable from those measured in control animals treated for 8 days with estradiol alone. These results demonstrate that sustained estrogen exposure downregulates levels of estrogen receptor in the brain and confirm that DHT synergizes with estrogen in inducing this response in some, but not all, target neuronal groups.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839355     DOI: 10.1159/000126935

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  23 in total

1.  Long-term replacement of estrogen in combination with medroxyprogesterone acetate improves acquisition of an alternation task in middle-aged female rats.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Behav Neurosci       Date:  2011-12-05       Impact factor: 1.912

Review 2.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

3.  Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus.

Authors:  L K Marriott; K R McGann-Gramling; B Hauss-Wegrzyniak; L C Sheldahl; R A Shapiro; D M Dorsa; G L Wenk
Journal:  Endocrine       Date:  2008-02-05       Impact factor: 3.633

4.  Continuously delivered ovarian steroids do not alter dendritic spine density or morphology in macaque dorsolateral prefrontal cortical neurons.

Authors:  M E Young; D T Ohm; W G M Janssen; N A Gee; B L Lasley; J H Morrison
Journal:  Neuroscience       Date:  2013-10-10       Impact factor: 3.590

Review 5.  Sex and the developing brain: suppression of neuronal estrogen sensitivity by developmental androgen exposure.

Authors:  N J MacLusky; D A Bowlby; T J Brown; R E Peterson; R B Hochberg
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

Review 6.  Gender specificity in the neural regulation of the response to stress: new leads from classical paradigms.

Authors:  V K Patchev; O F Almeida
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

7.  Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice.

Authors:  Stephanie M Fernandez; Karyn M Frick
Journal:  Behav Neurosci       Date:  2004-12       Impact factor: 1.912

Review 8.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

9.  Cerebral hypoperfusion increases estrogen receptor abundance in the ovine fetal brain and pituitary.

Authors:  Charles E Wood
Journal:  Neuroendocrinology       Date:  2007-12-21       Impact factor: 4.914

10.  Blockade of estrogen action upregulates estrogen receptor-alpha mRNA in the fetal brain.

Authors:  Christine E Schaub; Charles E Wood
Journal:  Neonatology       Date:  2009-03-12       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.